Ahead of his talk at EyeforPharma Barcelona next week, Medscape’s Ben Greenberg talks to pharmaphorum about the hype surrounding technology, and offers ideas about how to identify meaningful innovation.
The capabilities of artificial intelligence are advancing and its 'third wave' offers the ability to analyse enormous sets of data, identify patterns, and generate algorithms to explain them, t
Jay Bradner, head of Novartis’ drug discovery, talks to pharmaphorum about the firm’s drive to transform itself into 'a medicine and data science company'.
